<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.107193</article-id><article-id pub-id-type="publisher-id">ACM-36442</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200700000_79233819.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  动脉自旋标记技术在前循环大血管严重狭窄/闭塞患者中的应用价值
  Application Value of Arterial Spin Labeling in Patients with Severe Stenosis/Occlusion of Anterior Circulation Large Vessels
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>谷</surname><given-names>家美</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>雁</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学医学部，山东 青岛</addr-line></aff><aff id="aff3"><addr-line>青岛大学附属医院神经内科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>07</month><year>2020</year></pub-date><volume>10</volume><issue>07</issue><fpage>1269</fpage><lpage>1276</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：前循环大血管严重狭窄/闭塞造成的脑血管病是缺血性脑血管病中的一种重要类型，并且具有较高的复发率和致残率。本研究主要探讨动脉自旋标记(ASL)技术在未接受再灌注治疗的前循环大血管严重狭窄/闭塞患者中的应用价值。方法：序贯性收集于2017年6月至2019年6月就诊于青岛大学附属医院神经内科未接受再灌注治疗的172例前循环大血管严重狭窄/闭塞患者的临床及影像学资料。入院72 h内行磁共振成像(MRI)常规扫描T1加权成像(T1WI)、T2加权成像(T2WI)、液体衰减反转恢复(FLAIR)及弥散加权成像(DWI)、磁共振血管造影(MRA)或CT血管造影(CTA)、ASL技术检查。根据检查结果评价并记录患者的基本人口学及临床资料、血管严重狭窄/闭塞位置及程度、脑血流量(CBF)。根据DWI有无显示新发梗死灶及症状持续时间分为缺血性脑卒中组和短暂性脑缺血发作(TIA)组；采用单因素、多因素Logistic回归分析前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的独立危险因素。结果：129例有症状组患者中，109例为缺血性脑卒中组，20例为TIA组。缺血性脑卒中组与TIA组患者相比，空腹血糖较高，入院舒张压较低，狭窄侧CBF (PLD = 2.5 s)较低，差异有统计学意义(P &lt; 0.05)；多因素Logistic回归分析显示，入院舒张压(OR = 1.071, 95% CI: 1.023~1.122, P = 0.003)、狭窄侧CBF (PLD = 2.5 s) (OR = 1.035, 95% CI: 1.004~1.066, P = 0.027)是有症状的前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的独立保护因素。结论：入院舒张压、狭窄侧CBF (PLD = 2.5 s)是有症状的前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的独立保护因素。通过ASL技术测得的CBF对前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中有一定的预测价值，ASL技术在前循环大血管严重狭窄/闭塞患者中有很好的应用价值。
    Objective: Cerebrovascular disease caused by severe stenosis/occlusion of anterior circulation large vessels is an important type of ischemic cerebrovascular disease, and it has a high recurrence rate and disability rate. This study mainly explored the application value of arterial spin labeling (ASL) in patients with severe stenosis/occlusion of anterior circulation large vessels without reperfusion therapy. Methods: Sequential collection of clinical and imaging data from patients with severe stenosis/occlusion of the anterior circulation large vessels who had not received reperfusion therapy in the Department of Neurology of the Affiliated Hospital of Qingdao University from June 2017 to June 2019. Within 72 hours of admission, magnetic resonance imaging (MRI) routine scanning T1 weighted imaging (T1WI), T2 weighted imaging (T2WI), fluid attenuation inversion recovery (FLAIR) and diffusion weighted imaging (DWI), magnetic resonance angiography (MRA) or CT angiography (CTA), ASL examination were performed. The patient’s basic demographic and clinical data, the location and degree of severe stenosis or occlusion of vessels, and cerebral blood flow (CBF) are evaluated and recorded based on the examination results. According to whether DWI showed new infarct focus and the duration of symptoms, the patients were divided into cerebral infarction group and transient ischemic attack (TIA) group. Results: Of the 129 symptomatic patients, 109 were in the ischemic stroke group and 20 were in the TIA group. Compared with patients in the TIA group, the ischemic stroke group had higher fasting blood glucose, lower diastolic blood pressure at admission, and lower CBF (PLD = 2.5 s) on the stenosis side, the difference was statistically significant (P &lt; 0.05); multivariate logistic regression analysis showed that the diastolic blood pressure at admission (OR = 1.071, 95% CI: 1.023 - 1.122, P = 0.003) and CBF at the stenosis side (PLD = 2.5s) (OR = 1.035, 95% CI: 1.004 - 1.066, P = 0.027) were independent protective factors for ischemic stroke in patients with symptomatic severe stenosis/occlusion of anterior circulation large vessels. Conclusions: The diastolic blood pressure at admission and CBF at the stenosis side (PLD = 2.5 s) were independent protective factors for ischemic stroke in patients with symptomatic severe stenosis/occlusion of anterior circulation large vessels. The CBF measured by the ASL has certain predictive value for the occurrence of ischemic stroke in patients with severe stenosis/occlusion of anterior circulation large vessels; the ASL has good application value in patients with severe stenosis/occlusion of anterior circulation large vessels. 
  
 
</p></abstract><kwd-group><kwd>动脉自旋标记，脑血流量，缺血性脑卒中，预后, Arterial Spin Labeling</kwd><kwd> Cerebral Blood Flow</kwd><kwd> Ischemic Stroke</kwd><kwd> Prognosis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>动脉自旋标记技术在前循环大血管严重狭窄/闭塞患者中的应用价值</title><p>谷家美<sup>1</sup>，王雁<sup>2*</sup></p><p><sup>1</sup>青岛大学医学部，山东 青岛</p><p><sup>2</sup>青岛大学附属医院神经内科，山东 青岛</p><disp-formula id="hanspub.36442-formula19"><graphic xlink:href="//html.hanspub.org/file/19-1571402x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2020年6月5日；录用日期：2020年7月1日；发布日期：2020年7月8日</p><disp-formula id="hanspub.36442-formula20"><graphic xlink:href="//html.hanspub.org/file/19-1571402x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：前循环大血管严重狭窄/闭塞造成的脑血管病是缺血性脑血管病中的一种重要类型，并且具有较高的复发率和致残率。本研究主要探讨动脉自旋标记(ASL)技术在未接受再灌注治疗的前循环大血管严重狭窄/闭塞患者中的应用价值。方法：序贯性收集于2017年6月至2019年6月就诊于青岛大学附属医院神经内科未接受再灌注治疗的172例前循环大血管严重狭窄/闭塞患者的临床及影像学资料。入院72 h内行磁共振成像(MRI)常规扫描T1加权成像(T1WI)、T2加权成像(T2WI)、液体衰减反转恢复(FLAIR)及弥散加权成像(DWI)、磁共振血管造影(MRA)或CT血管造影(CTA)、ASL技术检查。根据检查结果评价并记录患者的基本人口学及临床资料、血管严重狭窄/闭塞位置及程度、脑血流量(CBF)。根据DWI有无显示新发梗死灶及症状持续时间分为缺血性脑卒中组和短暂性脑缺血发作(TIA)组；采用单因素、多因素Logistic回归分析前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的独立危险因素。结果：129例有症状组患者中，109例为缺血性脑卒中组，20例为TIA组。缺血性脑卒中组与TIA组患者相比，空腹血糖较高，入院舒张压较低，狭窄侧CBF (PLD = 2.5 s)较低，差异有统计学意义(P &lt; 0.05)；多因素Logistic回归分析显示，入院舒张压(OR = 1.071, 95% CI: 1.023~1.122, P = 0.003)、狭窄侧CBF (PLD = 2.5 s) (OR = 1.035, 95% CI: 1.004~1.066, P = 0.027)是有症状的前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的独立保护因素。结论：入院舒张压、狭窄侧CBF (PLD = 2.5 s)是有症状的前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的独立保护因素。通过ASL技术测得的CBF对前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中有一定的预测价值，ASL技术在前循环大血管严重狭窄/闭塞患者中有很好的应用价值。</p><p>关键词 :动脉自旋标记，脑血流量，缺血性脑卒中，预后</p><disp-formula id="hanspub.36442-formula21"><graphic xlink:href="//html.hanspub.org/file/19-1571402x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/19-1571402x8_hanspub.png" /> <img src="//html.hanspub.org/file/19-1571402x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>动脉自旋标记(arterial spin labeling, ASL)技术是一种基于磁共振成像(magnetic resonance imaging, MRI)的无创灌注成像技术，不需要外源性造影剂，而是利用自身动脉血内可自由弥散的水质子作为内源性示踪剂来完成脑灌注评价的一种功能磁共振成像(functional magnetic resonance imaging, fMRI)技术 [<xref ref-type="bibr" rid="hanspub.36442-ref1">1</xref>]，其可以通过测定局部组织血流量，进而反映器官的血流动力学变化 [<xref ref-type="bibr" rid="hanspub.36442-ref2">2</xref>]，尤其适用于碘过敏、甲状腺疾病和严重肾功能不全的人群。</p><p>ASL技术通过使供应大脑的血管内的水分子旋转反转或饱和来标记流向大脑的血液，到达毛细血管床后，这些标记的血液会与组织水交换，产生灌注加权信号，从标记的图像中减去未标记的会产生直接反映脑组织灌注的图像，该图像与脑血流量(cerebral blood flow, CBF)成正比 [<xref ref-type="bibr" rid="hanspub.36442-ref3">3</xref>]。血流从标记到获取图像的时间称为标记后延迟(posted labeling delay, PLD)时间，是ASL技术的一个重要参数，顺行血流通过一条较短的路径到达由狭窄血管供血的区域，因此较短PLD主要反映了顺行血流穿过动脉狭窄处提供的灌注，逆行侧支流经过相对较长和迂曲的路径，长PLD反映了逆行血流和一些缓慢的顺行血流提供的侧支灌注，单时相PLD容易低估脑灌注 [<xref ref-type="bibr" rid="hanspub.36442-ref4">4</xref>]。此外，ASL技术不仅可以显示CBF，还可以显示侧支循环建立情况及大血管闭塞信息，如动脉穿行伪影和高信号血管征分别显示灌注状态和大血管闭塞的信息 [<xref ref-type="bibr" rid="hanspub.36442-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.36442-ref6">6</xref>]。动脉穿行伪影是指侧支循环血管在CBF图上表现为脑皮质表面及皮质下区域匍匐走行、条状高灌注信号 [<xref ref-type="bibr" rid="hanspub.36442-ref7">7</xref>]。近端高信号血管征定义为闭塞动脉内的圆形或线性明亮高信号，而远端高信号血管征定义为受影响区域内或周围动脉内的圆形或线性明亮高信号 [<xref ref-type="bibr" rid="hanspub.36442-ref8">8</xref>]。高信号血管征的出现表明阻塞部位附近的动脉运输延迟或血流停滞 [<xref ref-type="bibr" rid="hanspub.36442-ref9">9</xref>]。</p><p>早期发现不良预后的预测因素和对不良预后高风险的前循环大血管严重狭窄/闭塞患者进行早期干预可能有助于减少不良预后。有研究评估基于ASL技术的软脑膜侧支灌注评分与大脑中动脉狭窄性缺血性脑卒中患者的血管内治疗结果的相关性，结果发现与不良结局患者相比，中度至良好结局患者的脑膜旁侧支灌注分数明显更高，表明通过ASL技术获得更高的软脑膜侧支灌注评分是大脑中动脉狭窄性缺血性脑卒中患者接受血管内治疗后良好临床结局的预测指标 [<xref ref-type="bibr" rid="hanspub.36442-ref10">10</xref>]，有学者发现对于早期行血运重建治疗后的缺血性脑卒中患者，ASL技术显示的高灌注与24小时美国国立卫生研究院卒中量表(national institute of health stroke scale, NIHSS)评分降低及90天较低改良Rankin量表(Modified Rankin Scale, mRS)评分有显著相关性 [<xref ref-type="bibr" rid="hanspub.36442-ref11">11</xref>]。但关于ASL技术在未接受再灌注治疗的前循环大血管严重狭窄/闭塞患者中的应用价值报道较少。本研究探讨ASL技术在未接受再灌注治疗的前循环大血管严重狭窄/闭塞患者中的应用价值。</p></sec><sec id="s4"><title>2. 研究对象</title><p>序贯性收集青岛大学附属医院神经内科自2017年6月至2019年6月收治的前循环大血管严重狭窄/闭塞并且未进行溶栓及血管内治疗的患者。纳入标准：1) 患者通过磁共振血管造影(magnetic resonance angiography, MRA)或CT血管造影(computed tomography angiograph, CTA)检查证实单侧颈内动脉或大脑中动脉严重狭窄或闭塞(≥70%)。2) 发病72 h内完成MRI常规扫描T1加权成像(T1 weighted imaging, T1WI)、T2加权成像(T2 weighted imaging T2WI)、液体衰减反转恢复(fluid attenuated inversion recovery, FLAIR)及DWI、MRA或CTA、ASL检查。3) 患者或家属签署知情同意书。排除标准：1) 双侧颈内动脉、大脑中动脉狭窄 ≥ 50%。2) 有急性心梗、房颤、心脏瓣膜病等心源性疾病引起的栓塞，颈内动脉和大脑中动脉支配区以外出现梗死病灶。3) 颈内动脉或大脑中动脉狭窄闭塞继发于其他明确病因，例如颈动脉蹼、颅内肉芽肿性动脉炎等任何已知的血管性疾病。4) 接受溶栓或血管内治疗的患者。5) 有MRI扫描的禁忌症，例如金属植入物和幽闭恐惧症；6) 患有重要器官严重疾病、恶性肿瘤等预期寿命少于3个月的患者。7) 患有血液系统疾病、严重的心力衰竭、自身免疫性疾病的患者。8) 资料不完整、失访。本研究为回顾性研究，获得青岛大学附属医院伦理审查委员会批准，并得到患者及家属的知情同意。</p></sec><sec id="s5"><title>3. 研究方法</title><sec id="s5_1"><title>3.1. 临床资料采集</title><p>序贯性收集所有入组患者的基本人口学及临床资料，包括年龄、性别、吸烟史、饮酒史、心房颤动史、脑梗死史、高血压病、糖尿病、冠心病、入院血压。</p></sec><sec id="s5_2"><title>3.2. 实验室检验指标</title><p>住院患者入院第二天抽取空腹血行血常规、血凝常规、空腹血糖、电解质、肝肾功等检验，采集空腹血糖、甘油三酯、总胆固醇、高密度脂蛋白(high density lipoprotein, HDL)、低密度脂蛋白(low density lipoprotein, LDL)、脂蛋白(a)、尿酸等指标，所有检验均由医院检验科完成。</p></sec><sec id="s5_3"><title>3.3. 影像资料收集</title><sec id="s5_3_1"><title>3.3.1. 检查方法</title><p>所有患者均应用GE Signa3.0 T超导型磁共振扫描仪，在标准8通道线圈内完成扫描。主要成像参数：1) 横轴面T1WI：TR 1750 ms，TE24 ms；T2WI：TR 3280 ms，TE 110 ms；2) 矢状位FLAIR：TR 9000 ms，TE 150 ms；3) DWI：TR 5300 ms，TE 81.4 ms；4) ASL：TR 1400 ms，TE 15 ms。扫描层厚5 mm，层间距1.5 mm，FOV 240 mm &#215; 240 mm，矩阵为320 &#215; 256。ASL进行双时相(PLD = 1.5 s及2.5 s)扫描。</p><p>每个患者的颅脑MRA检查应用GE Signa3.0 T超导型磁共振扫描仪，采用三维时间飞跃的磁共振血管造影(3D-TOF)，通过水平位、斜位的扫描方法，间距为1.2 mm，层厚6 mm，矩阵464 &#215; 512，经最大强度投影法(MIP)对原始图像进行三维重建获得MRA。</p><p>所有患者的头颈CTA检查应用飞利浦公司64层螺旋CT，管电压120 Kv/200 mAs，42 s内进行26次循环扫描，总共获得312张图片，然后将原始图像进行三维重建。</p></sec><sec id="s5_3_2"><title>3.3.2. 图像处理</title><p>将ASL扫描后的原始图像传输至GE ADW4.5工作站，进行图像处理后得到CBF图。由影像科医师分别对CBF (PLD = 1.5 s及2.5 s)图应用镜像法测感兴趣区(region of interest, ROI)及对侧镜像位置的CBF 值；选取时尽量避免大血管穿行区及脑脊液的影响，3次测量，求其平均值，获取平均CBF。动脉狭窄程度测量标准参照北美症状性颈动脉内膜剥脱试验(north American symptomatic carotid endarterectomy trial, NASCET):狭窄率(%) = [1 − (最狭窄处动脉直径/狭窄远端正常动脉直径)] &#215; 100% [<xref ref-type="bibr" rid="hanspub.36442-ref12">12</xref>]。</p></sec></sec><sec id="s5_4"><title>3.4. 定义及分组</title><p>患者缺血性脑卒中及TIA的诊断参照中国急性缺血性脑卒中诊治指南2018 [<xref ref-type="bibr" rid="hanspub.36442-ref13">13</xref>]。根据有神经功能缺损症状，分为有症状组和无症状组；根据DWI是否有新发脑梗死灶及症状持续时间分为缺血性脑卒中组和短暂性脑缺血发作(transient ischemic attack, TIA)组，DWI有新发脑梗死灶或者症状持续时间 ≥ 24小时为缺血性脑卒中组，DWI无新发梗死灶及症状持续时间 &lt; 24小时为TIA组。</p></sec></sec><sec id="s6"><title>4. 统计学方法</title><p>所有数据均采用统计学软件SPSS21.0完成统计学分析。首先采用Kolmogorov-Smirnov方法进行正态性检验，符合正态分布的计量资料采用均数&#177;标准差表示，两组间比较采用独立样本t检验；符合偏态分布的计量资料，采用中位数和四分位数间距(interquartile range, IQR)表示，两组间比较采用Mann-Whitney U检验。计数资料用百分比表示，组间比较采用卡方检验；多因素分析采用Logistic回归分析。先采用单因素分析统计影响患者发生缺血性脑卒的相关因素，然后将单因素分析中P &lt; 0.10的因素纳入多因素回归分析。所有检验均为双侧检验，P &lt; 0.05为差异具有显著性。</p></sec><sec id="s7"><title>5. 结果</title><sec id="s7_1"><title>5.1. 基本情况</title><p>最终共129例患者被纳入研究，均完善了MRI常规扫描T1WI、T2WI、FLAIR及DWI、MRA或CTA、ASL检查，其中男性92例，女性37例。</p></sec><sec id="s7_2"><title>5.2. 缺血性脑卒中组与TIA组临床资料及影像参数比较</title><p>129例有症状患者中，109例DWI显示梗死灶或症状持续时间 ≥ 24 h为缺血性脑卒中组，20例为TIA组。缺血性脑卒中组与TIA组患者相比，年龄无明显差异(P &gt; 0.05)，缺血性脑卒中组患者平均(63.15 &#177; 10.48)岁，TIA组患者平均(61.75 &#177; 14.05)岁，缺血性脑卒中组男性占71%，TIA组男性占75%，差异无统计学意义(P &gt; 0.05)；缺血性脑卒中组中位空腹血糖为5.55 mmol/L，(IQR: 4.80~6.76 mmol/L)，TIA组中位空腹血糖为5.11 mmol/L，(IQR: 4.51~5.56 mmol/L)，差异有统计学意义(P = 0.036 &lt; 0.05)；缺血性脑卒中组患者平均入院舒张压较TIA组患者低，差异有统计学意义(P = 0.001 &lt; 0.05)；缺血性脑卒中组患狭窄侧平均CBF (PLD = 2.5 s)和TIA组患狭窄侧平均CBF (PLD = 2.5 s)有显著差异(P = 0.012 &lt; 0.05)；吸烟史、饮酒史、心房颤动史、脑梗死史、高血压病、糖尿病、冠心病、血管狭窄侧、狭窄部位、狭窄程度、入院收缩压及部分生化指标、正常侧CBF (PLD = 1.5 s及2.5 s)、狭窄侧CBF (PLD = 1.5 s)无明显差异(P &gt; 0.05)。如表1所示。</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparison of clinical data and imaging parameters between ischemic stroke group and TIA grou</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >变量</th><th align="center" valign="middle" >缺血性脑卒中组(n = 109)</th><th align="center" valign="middle" >TIA组(n = 20)</th><th align="center" valign="middle" >t值/χ<sup>2</sup>值/Z值</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >年龄(岁)</td><td align="center" valign="middle" >63.15 &#177; 10.48</td><td align="center" valign="middle" >61.75 &#177; 14.05</td><td align="center" valign="middle" >0.518</td><td align="center" valign="middle" >0.605</td></tr><tr><td align="center" valign="middle" >男性[n(%)]</td><td align="center" valign="middle" >77 (0.71)</td><td align="center" valign="middle" >15 (0.75)</td><td align="center" valign="middle" >0.157</td><td align="center" valign="middle" >0.692</td></tr><tr><td align="center" valign="middle" >卒中危险因素</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >吸烟史[例(%)]</td><td align="center" valign="middle" >43 (0.39)</td><td align="center" valign="middle" >5 (0.25)</td><td align="center" valign="middle" >1.191</td><td align="center" valign="middle" >0.275</td></tr><tr><td align="center" valign="middle" >饮酒史[例(%)]</td><td align="center" valign="middle" >42 (0.39)</td><td align="center" valign="middle" >4 (0.20)</td><td align="center" valign="middle" >1.786</td><td align="center" valign="middle" >0.181</td></tr><tr><td align="center" valign="middle" >心房颤动史[例(%)]</td><td align="center" valign="middle" >11 (0.10)</td><td align="center" valign="middle" >1 (0.05)</td><td align="center" valign="middle" >0.091</td><td align="center" valign="middle" >0.763</td></tr><tr><td align="center" valign="middle" >脑梗死史[例(%)]</td><td align="center" valign="middle" >23 (0.21)</td><td align="center" valign="middle" >2 (0.10)</td><td align="center" valign="middle" >0.717</td><td align="center" valign="middle" >0.397</td></tr><tr><td align="center" valign="middle" >高血压病[例(%)]</td><td align="center" valign="middle" >76 (0.70)</td><td align="center" valign="middle" >12 (0.60)</td><td align="center" valign="middle" >0.737</td><td align="center" valign="middle" >0.391</td></tr><tr><td align="center" valign="middle" >糖尿病[例(%)]</td><td align="center" valign="middle" >33 (0.30)</td><td align="center" valign="middle" >6 (0.30)</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.980</td></tr><tr><td align="center" valign="middle" >冠心病[例(%)]</td><td align="center" valign="middle" >13 (0.12)</td><td align="center" valign="middle" >4 (0.20)</td><td align="center" valign="middle" >0.386</td><td align="center" valign="middle" >0.534</td></tr><tr><td align="center" valign="middle" >空腹血糖(mmol/L)</td><td align="center" valign="middle" >5.55 (4.80~6.76)</td><td align="center" valign="middle" >5.11 (4.51~5.56)</td><td align="center" valign="middle" >−2.092</td><td align="center" valign="middle" >0.036</td></tr><tr><td align="center" valign="middle" >甘油三酯(mmol/L)</td><td align="center" valign="middle" >1.31 (1.01~1.68)</td><td align="center" valign="middle" >1.07 (0.80~1.77)</td><td align="center" valign="middle" >−0.908</td><td align="center" valign="middle" >0.364</td></tr><tr><td align="center" valign="middle" >总胆固醇(mmol/L)</td><td align="center" valign="middle" >4.08 &#177; 1.26</td><td align="center" valign="middle" >4.01 &#177; 1.18</td><td align="center" valign="middle" >0.223</td><td align="center" valign="middle" >0.824</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >HDL (mmol/L)</th><th align="center" valign="middle" >1.10 (0.95~1.38)</th><th align="center" valign="middle" >1.12 (1.00~1.25)</th><th align="center" valign="middle" >−0.029</th><th align="center" valign="middle" >0.977</th></tr></thead><tr><td align="center" valign="middle" >LDL (mmol/L)</td><td align="center" valign="middle" >2.49 &#177; 1.02</td><td align="center" valign="middle" >2.31 &#177; 0.83</td><td align="center" valign="middle" >0.715</td><td align="center" valign="middle" >0.476</td></tr><tr><td align="center" valign="middle" >脂蛋白(a) (mmol/L)</td><td align="center" valign="middle" >165.30 (105.35~280.00)</td><td align="center" valign="middle" >171.00 (74.00~282.35)</td><td align="center" valign="middle" >−0.612</td><td align="center" valign="middle" >0.541</td></tr><tr><td align="center" valign="middle" >尿酸(μmol/L)</td><td align="center" valign="middle" >304.99 &#177; 89.26</td><td align="center" valign="middle" >312.95 &#177; 82.75</td><td align="center" valign="middle" >−0.370</td><td align="center" valign="middle" >0.712</td></tr><tr><td align="center" valign="middle" >入院收缩压(mmHg)</td><td align="center" valign="middle" >145.61 &#177; 21.73</td><td align="center" valign="middle" >140.15 &#177; 16.06</td><td align="center" valign="middle" >1.069</td><td align="center" valign="middle" >0.287</td></tr><tr><td align="center" valign="middle" >入院舒张压(mmHg)</td><td align="center" valign="middle" >81.51 &#177; 11.56</td><td align="center" valign="middle" >90.75 &#177; 9.65</td><td align="center" valign="middle" >0.552</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >病变血管</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.944</td><td align="center" valign="middle" >0.331</td></tr><tr><td align="center" valign="middle" >颈内动脉[例(%)]</td><td align="center" valign="middle" >57 (0.52)</td><td align="center" valign="middle" >10 (0.50)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >大脑中动脉[例(%)]</td><td align="center" valign="middle" >52 (0.48)</td><td align="center" valign="middle" >10 (0.50)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >狭窄/闭塞</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.022</td><td align="center" valign="middle" >0.883</td></tr><tr><td align="center" valign="middle" >闭塞[例(%)]</td><td align="center" valign="middle" >58 (0.53)</td><td align="center" valign="middle" >11 (0.55)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >严重狭窄[例(%)]</td><td align="center" valign="middle" >51 (0.47)</td><td align="center" valign="middle" >9 (0.45)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >狭窄侧为左侧[例(%)]</td><td align="center" valign="middle" >49 (0.45)</td><td align="center" valign="middle" >13 (0.65)</td><td align="center" valign="middle" >2.720</td><td align="center" valign="middle" >0.099</td></tr><tr><td align="center" valign="middle" >狭窄侧CBF (PLD = 1.5 s) [mL/(100 g∙min)]</td><td align="center" valign="middle" >21.00 (16.00~29.50)</td><td align="center" valign="middle" >26.50 (20.00~34.75)</td><td align="center" valign="middle" >−1.573</td><td align="center" valign="middle" >0.116</td></tr><tr><td align="center" valign="middle" >正常侧CBF (PLD = 1.5 s) [mL/(100 g∙min)]</td><td align="center" valign="middle" >41.82 &#177; 11.62</td><td align="center" valign="middle" >46.25 &#177; 13.27</td><td align="center" valign="middle" >−1.535</td><td align="center" valign="middle" >0.127</td></tr><tr><td align="center" valign="middle" >狭窄侧CBF (PLD = 2.5 s) [mL/(100 g∙min)]</td><td align="center" valign="middle" >36.89 &#177; 14.28</td><td align="center" valign="middle" >46.07 &#177; 17.78</td><td align="center" valign="middle" >−2.542</td><td align="center" valign="middle" >0.012</td></tr><tr><td align="center" valign="middle" >正常侧CBF (PLD = 2.5 s) [mL/(100 g∙min)]</td><td align="center" valign="middle" >43.70 &#177; 9.41</td><td align="center" valign="middle" >46.88 &#177; 10.72</td><td align="center" valign="middle" >−1.362</td><td align="center" valign="middle" >0.176</td></tr></tbody></table></table-wrap></table-wrap-group><p>表1. 缺血性脑卒中组与TIA组临床资料及影像参数比较</p><p>注：HDL：高密度脂蛋白；LDL：低密度脂蛋白；CBF：脑血流量；PLD：标记后延迟。</p></sec><sec id="s7_3"><title>5.3. 影响有症状的前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的多因素分析</title><p>将单因素分析中P &lt; 0.10的因素纳入多因素Logistic回归分析中，结果显示，入院舒张压(OR = 1.071, 95% CI: 1.023~1.122, P = 0.003)、狭窄侧CBF (PLD = 2.5 s) (OR = 1.035, 95% CI: 1.004~1.066, P = 0.027)是有症状的前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的独立保护因素。如表2所示。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Multivariate analysis of the occurrence of ischemic stroke in symptomatic patients with severe stenosis/occlusion of anterior circulation large vessel</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >变量</th><th align="center" valign="middle" >偏回归系数</th><th align="center" valign="middle" >偏回归系数标准误</th><th align="center" valign="middle" >wald x<sup>2</sup>值</th><th align="center" valign="middle" >OR值</th><th align="center" valign="middle" >95% CI</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >狭窄侧为左侧</td><td align="center" valign="middle" >0.714</td><td align="center" valign="middle" >0.563</td><td align="center" valign="middle" >1.608</td><td align="center" valign="middle" >2.041</td><td align="center" valign="middle" >0.677~6.151</td><td align="center" valign="middle" >0.205</td></tr><tr><td align="center" valign="middle" >空腹血糖</td><td align="center" valign="middle" >−0.409</td><td align="center" valign="middle" >0.216</td><td align="center" valign="middle" >3.584</td><td align="center" valign="middle" >0.664</td><td align="center" valign="middle" >0.435~1.015</td><td align="center" valign="middle" >0.058</td></tr><tr><td align="center" valign="middle" >入院舒张压</td><td align="center" valign="middle" >0.069</td><td align="center" valign="middle" >0.024</td><td align="center" valign="middle" >8.534</td><td align="center" valign="middle" >1.071</td><td align="center" valign="middle" >1.023~1.122</td><td align="center" valign="middle" >0.003</td></tr><tr><td align="center" valign="middle" >狭窄侧CBF (PLD = 2.5 s)</td><td align="center" valign="middle" >0.034</td><td align="center" valign="middle" >0.015</td><td align="center" valign="middle" >4.878</td><td align="center" valign="middle" >1.035</td><td align="center" valign="middle" >1.004~1.066</td><td align="center" valign="middle" >0.027</td></tr></tbody></table></table-wrap><p>表2. 影响有症状的前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的多因素分析</p><p>注：CBF：脑血流量；PLD：标记后延迟。</p></sec></sec><sec id="s8"><title>6. 讨论</title><p>本研究将有症状的前循环大血管严重狭窄/闭塞患者分为缺血性脑卒中组和TIA组，单因素分析结果提示，缺血性脑卒中组空腹血糖较高，可能是因为高血糖患者的毛细血管狭窄和阻塞不利于侧支循环的建立，促进缺血性脑卒中的发展 [<xref ref-type="bibr" rid="hanspub.36442-ref14">14</xref>]。有研究选取波兰2个综合性卒中中心行机械血栓切除术后的181例前循环缺血性脑卒中患者，分析空腹血糖与预后的关系，结果表明，空腹血糖是3个月不良预后的独立预测因子 [<xref ref-type="bibr" rid="hanspub.36442-ref15">15</xref>]。排除混杂因素后，缺血性脑卒中组的入院舒张压和狭窄侧CBF (PLD = 2.5 s)与TIA组仍有显著差异。有学者研究发现基线舒张压升高可有效改善缺血性脑卒中的侧支循环 [<xref ref-type="bibr" rid="hanspub.36442-ref16">16</xref>]，有研究表明，对于大血管严重狭窄/闭塞的患者，基线舒张压升高与侧支循环良好有关，但是基线收缩压升高可能与不良预后相关 [<xref ref-type="bibr" rid="hanspub.36442-ref17">17</xref>]，也有研究发现通过升高血压可以改善侧支循环，从而缩小梗死面积，改善预后 [<xref ref-type="bibr" rid="hanspub.36442-ref18">18</xref>]。本研究同样发现入院舒张压是有症状的前循环大血管严重狭窄/闭塞患者发生缺血性脑卒中的保护因素，并未发现与基线收缩压有关。有研究观察了症状发作后24小时内连续DWI显示阴性的TIA患者，并对其进行了评估，发现ASL技术灌注缺陷与病变同侧早期转化为缺血性脑卒中有关，ASL技术原始图像上出现的动脉穿行伪影与缺血性脑卒中转化呈负相关，高信号血管征与缺血性脑卒中转化呈正相关，并且这部分患者临床结局较差 [<xref ref-type="bibr" rid="hanspub.36442-ref19">19</xref>]。以上研究与本研究都表明，ASL技术显示低CBF (PLD = 2.5 s)的患者更容易发生缺血性脑卒中，长PLD主要显示逆向血流提供的灌注，较多逆向血流提供侧枝灌注减少缺血性脑卒中的发生。ASL技术有助于识别这些较少逆向血流的高危患者，并且加强抗血小板治疗和监测，防止缺血性脑卒中的发生。</p><p>本研究尚存在一定的局限性，第一，本研究为回顾性研究，在病例选择上可能存在偏倚，收集样本量较小且为单中心研究，有些患者在收集数据时化验指标不完整，导致部分数据丢失。第二，本研究将患者入院时测量血压纳入分析，可能存在测量错误及血压波动的情况。第三，对于检出&gt;50%的脑血管狭窄，MRA具有与DSA相当的等效性，据报道其敏感性和特异性分别为92%和91%，但低于CTA的敏感性(100%)和特异性(99%) [<xref ref-type="bibr" rid="hanspub.36442-ref20">20</xref>]。因此，我们期待将来开展大样本随机对照试验进一步探索ASL技术在前循环大血管严重狭窄/闭塞患者中的应用价值，为临床患者的治疗选择提供更加可靠的理论基础。</p></sec><sec id="s9"><title>文章引用</title><p>谷家美,王 雁. 动脉自旋标记技术在前循环大血管严重狭窄/闭塞患者中的应用价值Application Value of Arterial Spin Labeling in Patients with Severe Stenosis/Occlusion of Anterior Circulation Large Vessels[J]. 临床医学进展, 2020, 10(07): 1269-1276. https://doi.org/10.12677/ACM.2020.107193</p></sec><sec id="s10"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.36442-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Li, Z., Li, N., Qu, Y., et al. (2016) Application of 3.0T Magnetic Resonance Arterial Spin Labeling (ASL) Technology in Mild and Moderate Intracranial Atherosclerotic Stenosis. Experimental and Therapeutic Medicine, 12, 297-301.  
&lt;br&gt;https://doi.org/10.3892/etm.2016.3318</mixed-citation></ref><ref id="hanspub.36442-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Harston, G.W., Okell, T.W., Sheerin, F., et al. (2017) Quantification of Serial Cerebral Blood Flow in Acute Stroke Using Arterial Spin Labeling. Stroke, 48, 123-130. &lt;br&gt;https://doi.org/10.1161/STROKEAHA.116.014707</mixed-citation></ref><ref id="hanspub.36442-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bivard, A., Stanwell, P., Levi, C., et al. (2013) Arterial Spin Labeling Identifies Tissue Salvage and Good Clinical Recovery after Acute Ischemic Stroke. Journal of Neuroimaging, 23, 391-396.  
&lt;br&gt;https://doi.org/10.1111/j.1552-6569.2012.00728.x</mixed-citation></ref><ref id="hanspub.36442-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Lyu, J.H., Ma, N., Liebeskind, D.S., et al. (2016) Arterial Spin Labeling MRI Estimation of Antegrade and Collateral Flow in Unilateral Middle Cerebral Artery Stenosis. Stroke, 47, 428-433.  
&lt;br&gt;https://doi.org/10.1161/STROKEAHA.115.011057</mixed-citation></ref><ref id="hanspub.36442-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Yoo, R.E., Yun, T.J., Rhim, J.H., et al. (2015) Bright Vessel Appearance on Arterial Spin Labeling MRI for Localizing Arterial Occlusion in Acute Ischemic Stroke. Stroke, 46, 564-567. &lt;br&gt;https://doi.org/10.1161/STROKEAHA.114.007797</mixed-citation></ref><ref id="hanspub.36442-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sogabe, S., Satomi, J., Tada, Y., et al. (2017) Intra-Arterial High Signals on Arterial Spin Labeling Perfusion Images Predict the Occluded Internal Carotid Artery Segment. Neuroradiology, 59, 587-595.  
&lt;br&gt;https://doi.org/10.1007/s00234-017-1828-9</mixed-citation></ref><ref id="hanspub.36442-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Zaharchuk, G., Do, H.M., Marks, M.P., et al. (2011) Arterial Spin-Labeling MRI Can Identify the Presence and Intensity of Collateral Perfusion in Patients with Moyamoya Disease. Stroke, 42, 2485-2491.  
&lt;br&gt;https://doi.org/10.1161/STROKEAHA.111.616466</mixed-citation></ref><ref id="hanspub.36442-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Morofuji, Y., Horie, N., Tateishi, Y., et al. (2019) Arterial Spin Labeling Magnetic Resonance Imaging Can Identify the Occlusion Site and Collateral Perfusion in Patients with Acute Ischemic Stroke: Comparison with Digital Subtraction Angiography. Cerebrovascular Diseases, 48, 70-76. &lt;br&gt;https://doi.org/10.1159/000503090</mixed-citation></ref><ref id="hanspub.36442-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Tada, Y., Satomi, J., Abe, T., et al. (2014) Intra-Arterial Signal on Arterial Spin Labeling Perfusion MRI to Identify the Presence of Acute Middle Cerebral Artery Occlusion. Cerebrovascular Diseases, 38, 191-196.  
&lt;br&gt;https://doi.org/10.1159/000365653</mixed-citation></ref><ref id="hanspub.36442-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Lou, X., Yu, S., Scalzo, F., et al. (2017) Multi-Delay ASL Can Identify Leptomeningeal Collateral Perfusion in Endovascular Therapy of Ischemic Stroke. Oncotarget, 8, 2437-2443. &lt;br&gt;https://doi.org/10.18632/oncotarget.13898</mixed-citation></ref><ref id="hanspub.36442-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Shimonaga, K., Matsushige, T., Hosogai, M., et al. (2019) Hyperperfusion after Endovascular Reperfusion Therapy for Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases, 28, 1212-1218.  
&lt;br&gt;https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.01.007</mixed-citation></ref><ref id="hanspub.36442-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Weimar, C., Bilbilis, K., Rekowski, J., et al. (2017) Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy versus Isolated Coronary Artery Bypass Grafting. Stroke, 48, 2769-2775.  
&lt;br&gt;https://doi.org/10.1161/STROKEAHA.117.017570</mixed-citation></ref><ref id="hanspub.36442-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志, 2018, 51(9): 666-682.</mixed-citation></ref><ref id="hanspub.36442-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Southerland, A.M. and Johnston, K.C. (2012) Considering Hyperglycemia and Thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial. Annals of the New York Academy of Sciences, 1268, 72-78.  
&lt;br&gt;https://doi.org/10.1111/j.1749-6632.2012.06731.x</mixed-citation></ref><ref id="hanspub.36442-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Wnuk, M., Popiela, T., Drabik, L., et al. (2020) Fasting Hyperglycemia and Long-Term Outcome in Patients with Acute Ischemic Stroke Treated with Mechanical Thrombectomy. Journal of Stroke and Cerebrovascular Diseases, 29, Article ID: 104774. &lt;br&gt;https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104774</mixed-citation></ref><ref id="hanspub.36442-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Song, Q., Pan, R., Jin, Y., et al. (2020) Lymphocyte-to-Monocyte Ratio and Risk of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke. Neurological Sciences. &lt;br&gt;https://doi.org/10.1007/s10072-020-04355-z</mixed-citation></ref><ref id="hanspub.36442-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">洪澜, 程忻, 凌倚峰, 等. 急性缺血性卒中基线血压和侧支循环及预后的相关性研究[J]. 中华神经科杂志, 2018, 51(9): 699-704.</mixed-citation></ref><ref id="hanspub.36442-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Regenhardt, R.W., Das, A.S., Stapleton, C.J., et al. (2017) Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion. Frontiers in Neurology, 3, 317. &lt;br&gt;https://doi.org/10.3389/fneur.2017.00317</mixed-citation></ref><ref id="hanspub.36442-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Nam, K.W., Kim, C.K., Ko, S.B., et al. (2020) Regional Arterial Spin Labeling Perfusion Defect Is Associated with Early Ischemic Recurrence in Patients with a Transient Ischemic Attack. Stroke, 51, 186-192.  
&lt;br&gt;https://doi.org/10.1161/STROKEAHA.119.026556</mixed-citation></ref><ref id="hanspub.36442-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Haussen, D.C., Koch, S., Saraf-Lavi, E., et al. (2013) FLAIR Distal Hyperintense Vessels as a Marker of Perfusion- Diffusion Mismatch in Acute Stroke. Journal of Neuroimaging, 23, 397-400.  
&lt;br&gt;https://doi.org/10.1111/j.1552-6569.2012.00784.x</mixed-citation></ref></ref-list></back></article>